Progress in biomarkers of non-small cell lung cancer for individualized treatment
10.3867/j.issn.1000-3002.2016.04.012
- VernacularTitle:非小细胞肺癌生物标志物在个体化治疗方面的研究进展
- Author:
Changjiao LIU
;
Mingchun LI
- Publication Type:Journal Article
- Keywords:
non-small cell lung cancer;
biomarkers;
epidermal growth factor;
chemoradiotherapy
- From:
Chinese Journal of Pharmacology and Toxicology
2016;30(4):375-380
- CountryChina
- Language:Chinese
-
Abstract:
Biomarkers of non-small cell lung cancer(NSCLC)can facilitate an efficient diagnosis, improve therapeutic effects,reduce the side effects of other treatments,ameliorate prognosis and predict relapse of the disease and drug resistance. This paper summarized the biomarkers which were newly discovered and their functions in clinical practices in order to guide individualized treatment and help adjust treatment. The exploration of biomarkers of NSCLC will become a priority in future research.
